Late-extended adjuvant treatment: Does it work?

Diana Crivellari

Research output: Contribution to journalArticlepeer-review


Data from the National Institute of Canada IVIA.1 7 trial showed that patients who were disease free after 5 years of adjuvant treatment with tamoxifen had a 42% reduction of breast cancer recurrences (p <0.001) when they received a further treatment with the nonsteroidalJ aromatase inhibitor letrozole, immediately or within 3 montihs from the end of tamoxifen.

Original languageEnglish
Pages (from-to)237-240
Number of pages4
JournalAging Health
Issue number3
Publication statusPublished - Jun 2008


  • Aromatase inhibitors
  • Extended adjuvant therapy
  • Letrozole

ASJC Scopus subject areas

  • Medicine(all)
  • Geriatrics and Gerontology


Dive into the research topics of 'Late-extended adjuvant treatment: Does it work?'. Together they form a unique fingerprint.

Cite this